Zhejiang Ausun Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 205.11 million compared to CNY 143.99 million a year ago. Revenue was CNY 205.11 million compared to CNY 143.99 million a year ago. Net income was CNY 70.72 million compared to CNY 43.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.1786 compared to CNY 0.1071 a year ago. Diluted earnings per share from continuing operations was CNY 0.1786 compared to CNY 0.1071 a year ago.